Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 05/01/2012 - 05/01/2015

This course is closed. Please look for other available products in CPNP University.

Session Summary

Research in the pharmacogenomics of medications used for neuropsychiatric conditions has identified the potential for using this technology to personalize treatment by including genetic information. Understanding the biological basis of this technology as well as aspects of research study designs used in pharmacogenomic studies is essential for the clinical pharmacist to understand how to apply this information and its limitations. There are now laboratories that offer pharmacogenomic tests for selected variants in genes that are important for the pharmacokinetics and pharmacodynamics of many medications used in psychiatry practice. This session will provide attendees with information on the technology and studies behind the development of pharmacogenomics tests.

 

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • Receive a passing grade (60%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This session was presented live at the 2012 CPNP Annual Meeting. A PDF file of the slides and audio of the speaker’s presentation is provided. ACPE transcripts can be retrieved by participants online at cpnp.org and the credit will be automatically submitted to your account at CPE Monitor shortly after the evaluation is completed.

Faculty Information and Disclosures

Jeffrey R. Bishop, PharmD, MS, BCPP

View biographical information and disclosures

Learning Objectives

  1. Describe sources of genetic variability and how they may contribute to drug outcomes in psychiatry.
  2. Describe study designs commonly used in pharmacogenomics research.
  3. Describe the current status and future of the science enabling pharmacogenomics research.

Continuing Education Credit and Disclosures

Activity Dates: 05/01/2012 - 05/01/2015
ACPE Contact Hours: 1.0
ACPE Number: 0284-9999-12-016-H04-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPE Credit

The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

CME Credit

Sponsored by the University of Arizona College of Medicine at the Arizona Health Sciences Center.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint sponsorship of The University of Arizona College of Medicine at the Arizona Health Sciences Center and the College of Psychiatric and Neurologic Pharmacists. ACCME credit is no longer available for this course.

Nursing Credit

ACPE and ACCME approved contact hours are accepted for ANCC Certification Renewal (as quoted on the ANCC website):  “Other health disciplines' continuing education hours may be used if the content is applicable to your area of certification. ACPE and ACCME are specifically listed as approved credit types.

Grant Support

Annual Meeting Grant Supporter

Cyberonics

Genentech